3Wintzen M, Cilchrest BA. Proopiomelanocoroain,its derived peptides, and the skin[J]. J Invest Dermato1,2006,106(1 ):3-10.
4李义奎.中国药理学[M].北京:中国中医药出版社,1992:243.
5Tanu T, Toader S, Eanu I, et al.Pruritus in the elderly. Pathophysiological, clinical, laboratory and therapeutic ap- proach[J] .Rev Med Chir Soc Med Nat Iasi,2014,118( 1 ) : 33-38.
6Schmidt T, Sitaru C, Amber K, et al. BP180- and BP230- specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid? [J] .Br J Dermatol,2014, 171 (2) :212-219.
7Bretscher PA. On the mechanism determining the TH1/ TH2 phenotype of an immune response, and its pertinenceto strategies for the prevention, and treatment, of certain infectious diseases[ J ]. Scand J Immunol, 2014,79 (6) : 361-376.
8Zhang C, Xiao C, Wang P ,et al.The alteration of Thl/Th2! ThlT/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy [ J ]. Hum Immunol,2014, 75(4) :289-296.
9Chao GY, Wallis RH, Marandi L, et al. Iddm30 controls pancreatic expression of Ccll ! (Eotaxin) and the Thl/Th2 balance within the insulitic lesions [ J]. J Immunol, 2014, 192(8) : 3645-3653.
10Lin C, Lin HY, Chen JH, et al.Effects of paeonol on anti- neuroinflammatory responses in microglial cells[ J] .Int J Mol Sci, 2015,16 (4) : 8844-8860.
